Cargando…

Monoclonal Antibodies for the Prevention and Treatment of COVID-19 Disease in Patients With Hematological Malignancies: Two Case Reports and a Literature Review

Detalles Bibliográficos
Autores principales:	Klank, David, Hoffmann, Martin, Claus, Bernd, Zinke, Florian, Bergner, Raoul, Paschka, Peter
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2021
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8659996/ https://www.ncbi.nlm.nih.gov/pubmed/34901756 http://dx.doi.org/10.1097/HS9.0000000000000651

Ejemplares similares

Single Center Experience Using Monoclonal COVID-19 Antibodies in the Management of Immunocompromised Patients with COVID-19
por: Klank, David, et al.
Publicado: (2022)

Histological Findings in Kidney Biopsies of Patients with Monoclonal Gammopathy—Always a Surprise
por: Klank, David, et al.
Publicado: (2022)

Target Therapy in Hematological Malignances: New Monoclonal Antibodies
por: Podhorecka, Monika, et al.
Publicado: (2014)

Monoclonal antibodies targeting CD38 in hematological malignancies and beyond
por: van de Donk, Niels W. C. J., et al.
Publicado: (2016)

Monoclonal Antibody Therapies for Hematological Malignancies: Not Just Lineage-Specific Targets
por: Cuesta-Mateos, Carlos, et al.
Publicado: (2018)

Molecular Determinants Underlying the Anti-Cancer Efficacy of CD38 Monoclonal Antibodies in Hematological Malignancies
por: Mustafa, Nurulhuda, et al.
Publicado: (2022)

Bispecific Antibodies in the Treatment of Hematologic Malignancies
por: Duell, Johannes, et al.
Publicado: (2019)

Antiphospholipid Antibodies and Lipids in Hematological Malignancies
por: Barreno-Rocha, Sonia Guadalupe, et al.
Publicado: (2022)

Potential of the Dietary Antioxidants Resveratrol and Curcumin in Prevention and Treatment of Hematologic Malignancies
por: Kelkel, Mareike, et al.
Publicado: (2010)

Prevention of Infections in Patients with Hematological Malignancies
por: Nucci, Marcio, et al.
Publicado: (2012)

Prevention of Infections in Patients with Hematological Malignancies
por: Nucci, Marcio, et al.
Publicado: (2017)

Monoclonal antibodies for malaria prevention
por: Aleshnick, Maya, et al.
Publicado: (2022)

Pharmacokinetics of Monoclonal Antibodies
por: Ryman, Josiah T., et al.
Publicado: (2017)

Evaluation of SARS-CoV-2 Serological Testing in Patients with Multiple Myeloma and Other Hematologic Malignancies on Monoclonal Antibody Therapies
por: Mahimainathan, Lenin, et al.
Publicado: (2020)

A Canadian Perspective: Monoclonal Antibodies for Pre- and Post-Exposure Protection from COVID-19 in Vulnerable Patients with Hematological Malignancies
por: Owen, Carolyn, et al.
Publicado: (2022)

Trends in Malignant Glioma Monoclonal Antibody Therapy
por: Chekhonin, Ivan, et al.
Publicado: (2015)

Monoclonal antibodies in cervical malignancy-related HPV
por: Aghbash, Parisa Shiri, et al.
Publicado: (2022)

Targeting hedgehog signaling in myelofibrosis and other hematologic malignancies
por: Tibes, Raoul, et al.
Publicado: (2014)

Renal Diseases Associated with Hematologic Malignancies and Thymoma in the Absence of Renal Monoclonal Immunoglobulin Deposits
por: Morel, Antoine, et al.
Publicado: (2021)

Pharmaceutical Prevention and Management of Cardiotoxicity in Hematological Malignancies
por: Perpinia, Anastasia Stella, et al.
Publicado: (2022)

Antibody-Based Immunotherapeutic Strategies for the Treatment of Hematological Malignancies
por: Han, Yizhao, et al.
Publicado: (2020)

Bispecific Antibodies in Hematological Malignancies: A Scoping Review
por: Omer, Mohamed H., et al.
Publicado: (2023)

Histone Variants and Their Chaperones in Hematological Malignancies
por: Kirkiz, Ecem, et al.
Publicado: (2023)

Broadly neutralizing monoclonal antibodies for HIV prevention
por: Miner, Maurine D., et al.
Publicado: (2021)

Anti-CGRP Monoclonal Antibodies: the Next Era of Migraine Prevention?
por: Tso, Amy R., et al.
Publicado: (2017)

Influencing tumor-associated macrophages in malignant melanoma with monoclonal antibodies
por: Adams, Rebecca, et al.
Publicado: (2022)

Fusariosis in patients with hematological malignancies: Two case reports
por: Raymakers, Jord W., et al.
Publicado: (2023)

COVID-19 in Hematological Malignancies: Case Series and Literature Review
por: Ocheni, Sunday, et al.
Publicado: (2023)

Microbials for the production of monoclonal antibodies and antibody fragments
por: Spadiut, Oliver, et al.
Publicado: (2014)

Human monoclonal antibodies and monoclonal antibody multispecificity.
por: Campbell, A. M., et al.
Publicado: (1987)

Invasive Fungal Diseases in Children with Hematological Malignancies Treated with Therapies That Target Cell Surface Antigens: Monoclonal Antibodies, Immune Checkpoint Inhibitors and CAR T-Cell Therapies
por: Kyriakidis, Ioannis, et al.
Publicado: (2021)

Ribavirin for Chronic Hepatitis Prevention among Patients with Hematologic Malignancies
por: Tavitian, Suzanne, et al.
Publicado: (2015)

The Impact of Chemotherapy on Hepatitis B Antibody Titer in Patients with Hematological Malignancies
por: Yağcı, Münci, et al.
Publicado: (2015)

Assessment of disulfide and hinge modifications in monoclonal antibodies
por: Moritz, Bernd, et al.
Publicado: (2017)

Neutralizing monoclonal antibodies for COVID-19 treatment and prevention
por: Jaworski, Juan Pablo
Publicado: (2021)

The use of monoclonal antibody B72.3 in the management of gynecologic malignancies.
por: Simpson, J., et al.
Publicado: (1988)

Carbamazepine and Hematological Malignancies
por: Yavaşoğlu, İrfan, et al.
Publicado: (2013)

Malignant benign hematology
por: Sholzberg, Michelle
Publicado: (2018)

Neoantigens in Hematologic Malignancies
por: Biernacki, Melinda A., et al.
Publicado: (2020)

Deubiquitinases in hematological malignancies
por: Lei, Hu, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_9kvs9o3ijlfl094icm06rnojjr